The Relationship Between Generalized Anxiety Symptoms and Treatment Dropout Among Women in Residential Treatment for Substance Use Disorders

Background: Generalized anxiety disorder (GAD) co-occurs with substance use disorders (SUDs) at an alarmingly high rate, and the presence of anxiety is associated with an increased risk for relapse to substance use following treatment. Furthermore, comorbid SUDs and other forms of psychopathology ar...

Full description

Saved in:
Bibliographic Details
Published inSubstance use & misuse Vol. 51; no. 7; pp. 835 - 839
Main Authors Elmquist, JoAnna, Shorey, Ryan C., Anderson, Scott E., Stuart, Gregory L.
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 06.06.2016
Taylor & Francis Ltd
Subjects
alcohol abuse
Alcohol use
Anxiety
Anxiety-Depression
Comorbidity
Compliance
Dropping out
Drug abuse
Female
Females
Generalized anxiety disorder
Humans
Medical treatment
Medicine
Mental depression
Psychopathology
Relapse
Residential institutions
Residential Treatment
Risk
Substance abuse
Substance abuse treatment
Substance use disorder
substance use disorders
Substance-Related Disorders
Symptoms
Treatment compliance
treatment dropout
Women
drug abuse
Generalized anxiety disorder
treatment dropout
alcohol abuse
substance use disorders
Online AccessGet full text

Cover

More Information
Summary:Background: Generalized anxiety disorder (GAD) co-occurs with substance use disorders (SUDs) at an alarmingly high rate, and the presence of anxiety is associated with an increased risk for relapse to substance use following treatment. Furthermore, comorbid SUDs and other forms of psychopathology are associated with an increased risk for leaving treatment against medical advice (AMA). Objective and Method: Research has yet to examine whether the presence of GAD symptoms is associated with leaving treatment AMA in SUDs populations. Thus, the current study sought to address this important gap in the literature by examining this relationship among a sample of 122 women in residential treatment for SUDs. Results: Results demonstrated that GAD symptoms were significantly associated with the decision to leave treatment AMA after controlling for age, education, problematic alcohol and drug use, and depression symptoms. Conclusions/Importance: Our finding indicates the potential importance of assessing and targeting GAD in treatment for SUDs, which may increase treatment compliance.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1082-6084
1532-2491
DOI:10.3109/10826084.2016.1155612